Skip to content

Clinical trials

Epilepsies, Partial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Partial Clear all

238 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20024
20035
200412
200510
200610
200712
200813
20099
20106
201116
20127
20135
20144
20159
20163
20175
20187
20195
20204
202114
202212
20234
202416
202511
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed136
Recruiting34
Unknown status24
Terminated22
Active, not recruiting7
Withdrawn7
Not yet recruiting3
Enrolling by invitation3
Approved for marketing1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma17
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.15
SK Life Science, Inc.13
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.12
National Institute of Neurological Disorders and Stroke (NINDS)11
Pfizer8
Bial - Portela C S.A.7
GlaxoSmithKline7
Supernus Pharmaceuticals, Inc.5
Fondation Ophtalmologique Adolphe de Rothschild4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Partial238
Epilepsy114
Seizures76
Drug Resistant Epilepsy23
Epilepsy, Generalized10
Epilepsy, Complex Partial9
Brain Diseases8
Epilepsy, Temporal Lobe8
Lennox Gastaut Syndrome4
Anxiety Disorders3

Trials

Showing 51 to 75 of 238. Each trial links to its page on Pharma Observatory.

138 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.